Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Argus Research Downgrades Generac Hldgs to Hold

Argus Research Downgrades Generac Hldgs to Hold

Argus Research analyst John Eade downgrades Generac Hldgs (NYSE:GNRC) from Buy to Hold.

byBenzinga Newsdesk

November 25, 2022

1 minute read

Argus Research analyst John Eade downgrades Generac Hldgs (NYSE:GNRC) from Buy to Hold.

Vincerx Pharma’s Preclinical Data From Blood Cancer Candidate Shows Efficacy, Lower Toxicity

By Vandana Singh

April 19, 11:25 AM

Vincerx Pharma Inc (NASDAQ:VINC) presented a poster of VIP924 preclinical data at the 2023 American Association for Cancer Research (AACR) Annual…

VINC

Oragenics Appoints Janet Huffman As Chief Financial Officer Strengthening Executive Leadership Team Effective March 7

By Happy Mohamed

March 8, 10:13 AM

Oragenics, Inc. (NYSE:OGEN) ("Oragenics" or the "Company"), a biotechnology company dedicated to fighting infectious diseases including COVID-19, announces the appointment of Janet Huffman as

OGEN

Why Restaurant Company Yum China’s Shares Are Diving Today

By Lekha Gupta

November 1, 6:22 AM

Restaurant company Yum China Holdings Inc (NYSE: YUMC) shares are trading lower by over 12% after it reported

YUMC

News

Jana Partners Confirms In 13D Filing A 9.6% Stake In Freshpet

By Benzinga Newsdesk

September 22, 5:30 PM

-SEC Filing

FRPT

Argus Research Downgrades Generac Hldgs to Hold

Related Posts

Vincerx Pharma’s Preclinical Data From Blood Cancer Candidate Shows Efficacy, Lower Toxicity

Oragenics Appoints Janet Huffman As Chief Financial Officer Strengthening Executive Leadership Team Effective March 7

Why Restaurant Company Yum China’s Shares Are Diving Today

Jana Partners Confirms In 13D Filing A 9.6% Stake In Freshpet